Current challenges in the management of nonsmall cell lung cancer brain metastases
- PMID: 31896679
- DOI: 10.1183/13993003.01686-2019
Current challenges in the management of nonsmall cell lung cancer brain metastases
Conflict of interest statement
Conflict of interest: L.E.L. Hendriks reports other funding from Boehringer Ingelheim, BMS, Roche, Lilly and BMS; grants from Roche, Boehringer Ingelheim; grants and other funding from AstraZeneca; personal fees from Quadia, outside the submitted work. Conflict of interest: J. Cadranel reports grants from AstraZeneca, Boehringer Ingelheim, Novartis and Pfizer; personal fees from AstraZeneca, Boehringer Ingelheim, BMS, Lilly, MSD, Novartis, Pfizer, Roche and Takeda, outside the submitted work. Conflict of interest: T. Berghmans has nothing to disclose.
Comment on
-
Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey.Eur J Cancer. 2018 Apr;93:37-46. doi: 10.1016/j.ejca.2018.01.067. Epub 2018 Feb 21. Eur J Cancer. 2018. PMID: 29477100
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical